Gemphire Therapeutics Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Gemphire Therapeutics Inc.
CIK #0001638287
EDGAR Form CIK 2011 - 2025
10-K [0001638287]
10-Q [0001638287]
3 [0001638287]
4 [0001638287]
8-K [0001638287]
D [0001638287]
SC 13D [0001638287]
SC 13G [0001638287]
Form 13D/13G Filer Form 13D/13G Subject Filed
Armistice Capital LLC Metavia Inc [2025-02-14]
Armistice Capital LLC Neurobo Pharmaceuticals Inc [2024-11-14]
Strategic Risk LLC Neurobo Pharmaceuticals Inc [2023-03-28]
Altium Capital Management LP Neurobo Pharmaceuticals Inc [2022-11-17]
Dong-A St Co Ltd Neurobo Pharmaceuticals Inc [2021-03-11]
Freeman Roy Lester Neurobo Pharmaceuticals Inc [2020-02-13]
JK Biopharma Solutions Inc Neurobo Pharmaceuticals Inc [2020-01-10]
E&Investment Inc Neurobo Pharmaceuticals Inc [2020-01-10]
Dong-A St Co Ltd Neurobo Pharmaceuticals Inc [2020-01-09]
Neurobo Pharmaceuticals Inc Gemphire Therapeutics Inc [2019-08-02]
View All
Form 3/4/5 Subject 2011 - 2025
Woodworth Marshall H
MetaVia Inc.
Tursi James Patrick
Strickland D Gordon
Koven Andrew I
Salsbury Michael
Groves Jason L
Glickman Mark A
Dong-A St Co Ltd
Kim Hyung Heon
View All
Terms | Privacy | Guide
tony@aum13f.com